Foundations of Pediatric Growth Physiology: From Conceptus to Skeletal Maturation

Foundations of Pediatric Growth Physiology: From Conceptus to Skeletal Maturation

What determines whether a child conceived today will, in two decades, stand at the 3rd percentile or the 97th percentile of adult stature — and to what extent can that trajectory be deliberately shifted by nutritional intervention? This question, more than any other, organizes the entire discipline of pediatric growth optimization. It is not a question with a single answer. The biological substrate on which nutrition operates is itself the product of an evolutionary choreography that begins at conception and ends only when the epiphyses fuse — a process now understood to span approximately twenty-one years in females and twenty-three in males, with growth velocity that varies by more than an order of magnitude across that interval. The first task of this chapter is to deconstruct that choreography into its five canonical phases, each characterized by a distinct velocity curve, a distinct regulatory logic, and a distinct sensitivity to environmental perturbation. The second task is to descend from the level of the whole child to the level of the growth plate, where the cellular machinery of endochondral ossification actually executes the genetic and hormonal instructions received from above. The third task is to quantify the upper bound of nutritional modifiability by examining what genetics — through heritability estimates, GWAS-discovered loci, and polygenic prediction — does and does not determine. The fourth task is to ask whether populations, not just individuals, can be made taller, and to scrutinize the secular trend evidence for what it reveals about plasticity. The final task is to assemble these threads into a multifactorial model in which nutrition occupies a defined, measurable, but not unlimited, position. Only after this foundation has been laid can the specific hormonal axes (GH–IGF-1, thyroid, sex steroids, leptin) and the specific macronutrient and micronutrient levers be examined in the chapters that follow.

1. The Five Canonical Phases of Human Linear Growth

The velocity curve of human linear growth is famously non-monotonic. Unlike most mammalian species, which exhibit either a single prenatal-to-postnatal trajectory or a simple decelerating infantile curve, humans display a complex pattern that Karlberg first decomposed into three additive components — Infancy, Childhood, and Puberty (the so-called ICP model) — and which later work extended into a five-phase taxonomy that more accurately captures the prenatal contribution and the post-pubertal consolidation phase. Each phase has its own velocity envelope, its own primary regulator, and its own sensitivity profile to nutritional insult.

1.1 Phase I: The Prenatal Phase (Conception to Term)

Linear growth is most rapid, in absolute terms per unit time, during fetal life. Between 16 and 28 postmenstrual weeks, the long bones elongate at approximately 1.5 mm per day — a velocity roughly fivefold greater than the fastest postnatal rate. By term, crown–heel length has progressed from a single fertilized ovum to approximately 50 cm, an increase requiring the coordinated proliferation and hypertrophy of billions of chondrocytes. The regulator of this phase is not growth hormone. Fetal somatotrophs produce GH from approximately 10 weeks, but fetal serum GH concentrations are extraordinarily high while IGF-1 concentrations are relatively low, and the few cases of GH receptor deficiency (Laron syndrome) in utero are associated with only modest length deficit at birth. Instead, the dominant inputs are placental nutrient transfer (glucose, amino acids, lactate), fetal insulin (the principal anabolic hormone of the fetal period), and IGF-2 (the principal fetal growth factor, expressed from the paternal allele and imprinted on the maternal allele in a pattern conserved across mammals). Maternal nutrition, placental function, and uteroplacental blood flow therefore set the boundary conditions for Phase I; severe maternal undernutrition (as in the Dutch Hunger Winter of 1944–1945) reduces mean birth length by approximately 1–2 cm, and severe maternal hyperglycemia increases it via fetal hyperinsulinemia. The clinical relevance of this phase for the rest of this book is that the prenatal velocity envelope establishes the starting point on the postnatal growth curve, and departures from the genetic trajectory in this phase may or may not be recoverable depending on whether catch-up growth is available in Phase II.

1.2 Phase II: The Infancy Phase (Birth to ~24–36 Months)

The infantile phase is defined by a continuously decelerating velocity. Peak postnatal velocity occurs in the first two months, when the term infant gains approximately 3–4 cm per month, then declines to approximately 1.5 cm/month by six months, 1 cm/month by twelve months, and approximately 0.5 cm/month by two years. The cumulative height gain from birth to age 2 is approximately 35 cm — meaning that nearly half of the postnatal stature attained by adulthood has been achieved by the time the child is 24 months old. This is the Karlberg "Infancy" component of the ICP model, and its regulatory logic differs from Phase I. GH begins to assume a measurable role by approximately 6 months, and thyroid hormone is essential for normal velocity, but the dominant determinant during the first 6 months remains nutritional intake and the macronutrient composition of the diet. Infants who experience severe undernutrition (marasmus) during this phase suffer not only stunting but a reprogramming of metabolic set-points, and their catch-up, when refeeding occurs, is often incomplete. The window for recovery is finite: although some catch-up can occur into the third and fourth year, the velocity of the infantile phase cannot be re-entered. This phase is also the period of greatest nutritional sensitivity in postnatal life — a fact that explains the global epidemiology of stunting, where prevalence rises most steeply between 6 and 24 months in low- and middle-income countries.

1.3 Phase III: The Childhood Phase (~2 Years to Pubertal Onset)

The childhood phase is characterized by a low, relatively stable velocity of approximately 5–6 cm per year, with a slow deceleration from approximately 8 cm/year at age 2 to approximately 5 cm/year immediately before puberty. This is the phase in which growth hormone assumes primacy as the hormonal regulator, with IGF-1 acting as the principal mediator at the growth plate. Thyroid hormone remains necessary but permissive; cortisol in physiological concentrations supports normal velocity, but excess glucocorticoid exposure is profoundly suppressive. The childhood phase is also the longest of the five phases, spanning approximately 8–10 years, and it is during this phase that cumulative height gain is approximately 50–55 cm — a substantial absolute contribution that is easy to underweight because the velocity appears low. Nutritional intervention during this phase yields incremental gains that are smaller than those achievable in infancy but more durable: a chronically malnourished child provided with adequate macronutrients and key micronutrients during the childhood phase can gain 5–10 cm above their deficient trajectory, with most of that gain retained through puberty. The childhood phase is also the phase in which the secular trend is most evident in well-nourished populations — the incremental gains in adult stature seen across generations in industrialized countries over the twentieth century reflect changes that occur predominantly in this window.

1.4 Phase IV: The Pubertal Phase

Pubertal growth is biphasic. An initial acceleration in velocity begins at approximately Tanner breast stage 2 in girls (mean age 10.5–11) and testicular volume 4 mL in boys (mean age 11.5–12), with peak height velocity (PHV) reached approximately 2 years later. PHV averages approximately 8–9 cm/year in girls and approximate